Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry


Report Abuse


Bacterial and fungal microbiota will be different between individual body sites; however, particular microbiome profiles both whole-body and site-specific will be unique to volunteers with a given parameter such as medical diagnosis, diet, medications taken, geographical area; etc.

Targeted Conditions

Study Overview

Start Date
January 1, 2020
Completion Date
December 31, 2030
Date Posted
January 19, 2022
Accepts Healthy Volunteers?


Full Address
University Hospitals Cleveland Medical Center
Cleveland, Ohio 44106, United States


Study Population
Volunteers will be age 18 years or older and capable of giving informed consent and able and willing to complete all required study specified procedures
Minimum Age (years)
Eligibility Criteria
Inclusion Criteria:

Capable of giving informed consent.
Able and willing to complete all required specified study procedures

Exclusion Criteria:

Antibiotic or antifungal use whether topical or systemic in the past 2 or 4 weeks, respectively.
Unable and/or unwilling to complete all required study procedures.

Study Contact Info

Study Contact Name
Mahmoud Ghannoum, PhD
Study Contact Email
Study Contact Phone

Contact Listings Owner Form

Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Other Details

FDA Regulated Drug?
FDA Regulated Device?
Detailed Description
Specific aims:

Identify and characterize whole-body and site-specific microbiome profiles.
Identify phenotypic microbiome profiles unique to individual parameters such as demographics, medical diagnoses, diet; etc.
Perform bacterial-bacterial, fungal-fungal and bacterial-fungal correlation analysis to identify potential synergistic and antagonistic species within these unique profiles.
NCTid (if applicable)